Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-14 Sale |
2021-05-18 8:17 pm |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
27,778 | $25.34 | $703,983 | 30,402 (Direct) |
View |
2021-05-11 Sale |
2021-05-13 8:00 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
100 | $25.11 | $2,511 | 239,600 (Indirect Direct) |
View |
2021-05-11 Sale |
2021-05-13 7:59 pm |
Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director |
503 | $25.1 | $12,623 | 48,997 (Direct) |
View |
2021-05-11 Sale |
2021-05-13 7:57 pm |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
2,220 | $25.13 | $55,780 | 58,180 (Direct) |
View |
2021-04-28 Sale |
2021-04-30 7:59 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
200 | $25.17 | $5,034 | 239,700 (Indirect Direct) |
View |
2021-04-28 Sale |
2021-04-30 7:57 pm |
Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director |
300 | $25.14 | $7,541 | 49,500 (Direct) |
View |
2021-04-28 Sale |
2021-04-30 7:56 pm |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
1,300 | $25.14 | $32,685 | 60,400 (Direct) |
View |
2021-04-01 Sale |
2021-04-05 7:45 pm |
Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director |
200 | $25 | $5,000 | 49,800 (Direct) |
View |
2021-04-01 Sale |
2021-04-05 7:42 pm |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
100 | $25 | $2,500 | 239,900 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-05 7:40 pm |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
800 | $25.09 | $20,070 | 61,700 (Direct) |
View |
2021-03-29 Sale |
2021-03-31 5:11 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
103,424 | $23.48 | $2,428,092 | 2,212,571 (Indirect) |
View |
2021-03-29 Sale |
2021-03-31 5:08 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
103,424 | $23.48 | $2,428,092 | 2,212,571 (Indirect) |
View |
2021-03-24 Sale |
2021-03-26 5:51 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
112,298 | $24.53 | $2,754,247 | 2,315,995 (Indirect) |
View |
2021-03-24 Sale |
2021-03-26 5:46 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
112,298 | $24.53 | $2,754,247 | 2,315,995 (Indirect) |
View |
2021-03-19 Sale |
2021-03-23 5:26 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
32,940 | $26.21 | $863,339 | 2,428,293 (Indirect) |
View |
2021-03-19 Sale |
2021-03-23 5:22 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
32,940 | $26.21 | $863,339 | 2,428,293 (Indirect) |
View |
2021-03-16 Sale |
2021-03-18 9:07 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
66,202 | $27.95 | $1,850,339 | 2,461,233 (Indirect) |
View |
2021-03-16 Sale |
2021-03-18 9:04 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
66,202 | $27.95 | $1,850,339 | 2,461,233 (Indirect) |
View |
2021-03-11 Sale |
2021-03-15 8:55 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
238,282 | $30.54 | $7,275,986 | 2,527,435 (Indirect) |
View |
2021-03-11 Sale |
2021-03-15 8:50 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director |
238,282 | $30.54 | $7,275,986 | 2,527,435 (Indirect) |
View |
2020-11-04 Sale |
2020-11-05 08:56 am |
Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner |
2,268,750 | $0 | $0 | 1,100,446 (Indirect) |
View |
2020-04-24 Purchase |
2020-04-28 5:13 pm |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
281,250 | $16 | $4,500,000 | 2,765,717 (Indirect) |
View |
2020-04-24 Purchase |
2020-04-28 5:07 pm |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner |
281,250 | $16 | $4,500,000 | 2,765,717 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-01 Option Award |
2021-02-02 7:32 pm |
N/A 2031-01-31 |
Oric Pharmaceuticals Inc. | ORIC | Piscitelli Dominic Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2021-02-01 Option Award |
2021-02-02 7:31 pm |
N/A 2031-01-31 |
Oric Pharmaceuticals Inc. | ORIC | Multani Pratik S Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2021-02-01 Option Award |
2021-02-02 7:29 pm |
N/A 2031-01-31 |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
280,000 | $0 | 280,000 (Direct) |
View |
2020-06-09 Option Award |
2020-06-10 5:09 pm |
N/A 2030-06-08 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
28,515 | $0 | 28,515 (Direct) |
View |
Ownership |
2020-06-10 5:07 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
0 | $0 | 0 (Direct) |
View |
2020-04-28 Conversion |
2020-04-28 5:42 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner |
4,693,181 | $0 | 4,768,181 (Direct) |
View |
2020-04-28 Conversion |
2020-04-28 5:13 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
2,484,467 | $0 | 2,765,717 (Indirect) |
View |
2020-04-28 Conversion |
2020-04-28 5:11 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner |
3,312,624 | $0 | 3,312,624 (Direct) |
View |
2020-04-28 Conversion |
2020-04-28 5:10 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner |
4,693,181 | $0 | 4,768,181 (Indirect) |
View |
2020-04-28 Conversion |
2020-04-28 5:09 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director |
25,000 | $0 | 50,000 (Direct) |
View |
2020-04-28 Conversion |
2020-04-28 5:08 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director |
62,500 | $0 | 240,000 (Indirect) |
View |
2020-04-28 Conversion |
2020-04-28 5:07 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner |
2,484,467 | $0 | 2,765,717 (Indirect) |
View |
2020-04-28 Conversion |
2020-04-28 5:06 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob President and CEO |
62,500 | $0 | 62,500 (Direct) |
View |